Whittles LK, Didelot X, White PJ. Public health impact and cost-effectiveness of gonorrhoea vaccination: an integrated transmission-dynamic health-economic modelling analysis. Lancet Infect Dis 2022; published online April 12. https://doi.org/10.1016/S1473-3099(21)00744-1—In the Summary of this Article, the first sentence of the Interpretation has been amended to “We recommend that vaccination of MSM against gonorrhoea according to risk in sexual health clinics in England with the 4CMenB vaccine be considered.” This correction has been made to the online version as of April 29, 2022, and will be made to the printed version.
. 2022 Jun;22(6):e159. doi: 10.1016/S1473-3099(22)00280-8
Correction to Lancet Infect Dis 2022; published online April 12. https://doi.org/10.1016/S1473-3099(21)00744-1
© 2022 The Author(s). Published by Elsevier Ltd.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
PMCID: PMC9132774 PMID: 35500591
This corrects the article "Public health impact and cost-effectiveness of gonorrhoea vaccination: an integrated transmission-dynamic health-economic modelling analysis" on page 1030.